LifeMD
LFMD
40 hedge funds and large institutions have $10.5M invested in LifeMD in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
28% more call options, than puts
Call options by funds: $220K | Put options by funds: $172K
0% more funds holding
Funds holding: 40 → 40 (0)
0.65% less ownership
Funds ownership: 17.94% → 17.29% (-0.65%)
6% less capital invested
Capital invested by funds: $11.3M → $10.5M (-$732K)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$620K |
| 2 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$238K |
| 3 |
SCM
Shah Capital Management
Raleigh,
North Carolina
|
+$150K |
| 4 |
Bank of New York Mellon
New York
|
+$77.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$70.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$328K |
| 2 |
Two Sigma Advisers
New York
|
-$313K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$244K |
| 4 |
Two Sigma Investments
New York
|
-$143K |
| 5 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$119K |
LFMD Hedge Fund Activity: Q3 2022 in Review
40 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q3 2022, worth a combined $10.5M — down 6.5% from $11.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LFMD positions and 3 closed out — a net gain of 2 holders — while 9 added to existing stakes and 15 trimmed.
The largest buyer was Royce & Associates, adding an estimated $620K. The largest seller was Granahan Investment Management, cutting an estimated $328K.
- 40 institutional investors held LifeMD (LFMD) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $10.5M of LifeMD stock for Q3 2022, down 6.5% quarter-over-quarter.
- 5 funds opened new LifeMD positions in Q3 2022 and 3 closed out, a net change of +2 holders.
- The largest LifeMD buyer in Q3 2022 was Royce & Associates, an estimated $620K added.
- The largest LifeMD seller in Q3 2022 was Granahan Investment Management, an estimated $328K sold.
Based on aggregated 13F filings for Q3 2022.